Fig. 6From: Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trialsCross-sector perceptions of potential facilitators to the use of adaptive designs (ADs) in confirmatory trials. Denominators: public funders (n = 64), UK Clinical Trials Units (CTUs) (n = 25), and private sector organisations (n = 13)Back to article page